Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Oct;33(10):2181-3.
doi: 10.2337/dc10-0964. Epub 2010 Jul 27.

Effectiveness of a computerized insulin order template in general medical inpatients with type 2 diabetes: a cluster randomized trial

Deborah J Wexler  1 , Peter Shrader, Sean M Burns, Enrico Cagliero
Affiliations
Randomized Controlled Trial

Effectiveness of a computerized insulin order template in general medical inpatients with type 2 diabetes: a cluster randomized trial

Deborah J Wexler et al. Diabetes Care. 2010 Oct.

Abstract

Objective: To determine whether an electronic order template for basal-bolus insulin ordering improves mean blood glucose in hospitalized general medical patients with hyperglycemia and type 2 diabetes.

Research design and methods: We randomly assigned internal medicine resident teams on acute general medical floors to the use of an electronic insulin order template or usual insulin ordering. We measured diabetes care parameters for 1 month on all patients with type 2 diabetes and blood glucose <60 mg/dl or >180 mg/dl treated by these physicians.

Results: Intervention group patients (n = 65) had mean glucose of 195 ± 66 mg/dl. Control group patients (n = 63) had mean glucose of 224 ± 57 mg/dl (P = 0.004). In the intervention group, there was no increase in hypoglycemia.

Conclusions: Access to a computer insulin order template was associated with improved mean glucose levels without increasing hypoglycemia in patients with type 2 diabetes.

PubMed Disclaimer

References

    1. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R: Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007; 30: 2181– 2186 - PubMed
    1. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE: American Association of Clinical Endocrinologists, American Diabetes Association American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009; 15: 353– 369 - PubMed
    1. Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW: Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care 2007; 30: 367– 369 - PubMed
    1. Maynard G, Lee J, Phillips G, Fink E, Renvall M: Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med 2009; 4: 3– 15 - PubMed
    1. Donihi AC, DiNardo MM, DeVita MA, Korytkowski MT: Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Qual Saf Health Care 2006; 15: 89– 91 - PMC - PubMed

Publication types